Ke Wu

2.4k total citations
68 papers, 1.5k citations indexed

About

Ke Wu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Ke Wu has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in Ke Wu's work include Cancer Immunotherapy and Biomarkers (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Immune cells in cancer (8 papers). Ke Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Immune cells in cancer (8 papers). Ke Wu collaborates with scholars based in China, United States and Switzerland. Ke Wu's co-authors include Zhong Zheng, Zhixian Yao, Junhua Zheng, Didier Sornette, Didier Darcet, Qian Wang, Guobin Wang, Kaixiong Tao, Zhihong Liu and Bo Wen and has published in prestigious journals such as Cell Metabolism, Biochemical and Biophysical Research Communications and Science Advances.

In The Last Decade

Ke Wu

64 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ke Wu China	22	451	413	342	304	231	68	1.5k
Corrie Painter United States	21	365 0.8×	385 0.9×	505 1.5×	277 0.9×	447 1.9×	44	1.9k
Jianming Tang China	20	1.1k 2.5×	174 0.4×	319 0.9×	819 2.7×	560 2.4×	57	2.4k
Aïcha Goubar France	23	425 0.9×	836 2.0×	1.3k 3.9×	374 1.2×	157 0.7×	51	2.4k
Liang Hong China	16	352 0.8×	307 0.7×	218 0.6×	86 0.3×	685 3.0×	45	1.9k
Ling Zhang United States	18	403 0.9×	161 0.4×	301 0.9×	92 0.3×	673 2.9×	113	1.8k
Kishore B. Challagundla United States	21	1.3k 2.9×	212 0.5×	390 1.1×	814 2.7×	96 0.4×	41	1.9k
Vaishali R. Moulton United States	23	592 1.3×	1.3k 3.1×	320 0.9×	147 0.5×	427 1.8×	37	2.5k
Ci Song China	17	221 0.5×	84 0.2×	290 0.8×	117 0.4×	810 3.5×	62	1.9k

Countries citing papers authored by Ke Wu

Since Specialization

Citations

This map shows the geographic impact of Ke Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Wu more than expected).

Fields of papers citing papers by Ke Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Wu. The network helps show where Ke Wu may publish in the future.

Co-authorship network of co-authors of Ke Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Wu. A scholar is included among the top collaborators of Ke Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Wu. Ke Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Ke, Junliang Zhang, & Junfeng Yang. (2025). Synthesis of sulfilimines via electron donor–acceptor complexes. Organic Chemistry Frontiers. 12(24). 7118–7126. 1 indexed citations

Ma, Jinxin, Ziheng Chen, Ke Wu, Jiahui Lei, & Limin Zhao. (2024). Risk factor analysis and nomogram for predicting poor symptom control in smoking asthmatics. BMC Pulmonary Medicine. 24(1). 264–264. 1 indexed citations

Stingone, Jeanette A., Andrew M. Geller, Darryl B. Hood, et al.. (2023). Community-level exposomics: a population-centered approach to address public health concerns. PubMed. 3(1). 13 indexed citations

Wu, Ke, Weiguang Zhao, Zhixian Yao, et al.. (2023). The microbiota and renal cell carcinoma. Cellular Oncology. 47(2). 397–413. 11 indexed citations

Wu, Ke, et al.. (2023). LY6/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment. Biology Direct. 18(1). 72–72. 5 indexed citations

Wu, Ke, et al.. (2023). A safe and simple exposure and Pringle maneuver in laparoscopic anatomical liver resection of segment 7. BMC Gastroenterology. 23(1). 418–418.

Zha, Lisha, Xinyue Chang, Hongxin Zhao, et al.. (2021). Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles. Vaccines. 9(4). 395–395. 36 indexed citations

Gu, Junnan, Shuang Yao, Yinghao Cao, et al.. (2021). Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients. World Journal of Gastrointestinal Surgery. 13(7). 689–701. 5 indexed citations

Zheng, Zhong, Weiguang Zhao, Feng Sun, et al.. (2021). IL‐6 Promotes the Proliferation and Immunosuppressive Function of Myeloid‐Derived Suppressor Cells via the MAPK Signaling Pathway in Bladder Cancer. BioMed Research International. 2021(1). 5535578–5535578. 21 indexed citations

10.

Yan, Yi, Ke Wu, Jun Chen, et al.. (2021). Rapid Acquisition of High-Quality SARS-CoV-2 Genome via Amplicon-Oxford Nanopore Sequencing. Virologica Sinica. 36(5). 901–912. 16 indexed citations

11.

Wu, Ke, et al.. (2020). Relationship between tumor heterogeneity and volume in cervical cancer: Evidence from integrated fluorodeoxyglucose 18 PET/MR texture analysis. Nuclear Medicine Communications. 42(5). 545–552. 3 indexed citations

12.

Wu, Ke, Didier Darcet, Qian Wang, & Didier Sornette. (2020). Generalized logistic growth modeling of the COVID-19 outbreak: comparing the dynamics in the 29 provinces in China and in the rest of the world. Nonlinear Dynamics. 101(3). 1561–1581. 140 indexed citations

13.

Li, J., Nan You, Ke Wu, et al.. (2020). P-129 Camrelizumab combined with sorafenib versus sorafenib alone in patients with advanced hepatocellular carcinoma: A retrospective study. Annals of Oncology. 31. S131–S132. 2 indexed citations

14.

Wang, Jiahui, Huan Liu, Ke Wu, et al.. (2020). Can the reform of integrating health insurance reduce inequity in catastrophic health expenditure? Evidence from China. International Journal for Equity in Health. 19(1). 49–49. 39 indexed citations

15.

Zheng, Zhong, Zhixian Yao, Ke Wu, & Junhua Zheng. (2020). The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test. Journal of Clinical Virology. 128. 104396–104396. 17 indexed citations

16.

Wu, Ke, Jie Zhu, Lili Zhou, et al.. (2020). Lactational changes of fatty acids and fat-soluble antioxidants in human milk from healthy Chinese mothers. British Journal Of Nutrition. 123(8). 841–848. 17 indexed citations

17.

Zhou, Wen‐Jie, Haoyu Wang, Haiying Dai, et al.. (2020). NEAT1/miR-200b-3p/SMAD2 axis promotes progression of melanoma. Aging. 12(22). 22759–22775. 37 indexed citations

18.

Zheng, Zhong, Ke Wu, Xingyu Mu, et al.. (2019). Prognostic nomogram for bladder cancer with brain metastases: a National Cancer Database analysis. Journal of Translational Medicine. 17(1). 411–411. 21 indexed citations

19.

Li, Wei, Takashi Tanikawa, Ilona Kryczek, et al.. (2018). Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metabolism. 28(1). 87–103.e6. 326 indexed citations

20.

Cao, Yinghao, Lijuan Xiong, Shenghe Deng, et al.. (2018). The effect of perigastric lipolymphatic tissue grouping by surgeon on the number of pathologic sampled lymph nodes after radical gastrectomy. Medicine. 97(27). e11411–e11411. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact